Prof. Dr. Fabio Piscaglia is currently working as a Full Professor of Internal Medicine at the University of Bologna, Italy and is Director of the Division of Internal Medicine, Hepatobiliary and Immunoallergic Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna. He was President of the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) for the term 2011–2013. He is an Honorary Member of the Rumanian Society of Ultrasound in Medicine. He is a member of the working group of the American College of Radiology ACR, which released an innovative recommendation for the characterisation and reporting of focal liver lesions at risk of hepatocellular carcinoma in 2016, the CEUS LI-RADS classification. He actively participated as Principal Investigator to successful grants from the NIH and European Union and is the PI of several international sponsored trials in hepatocellular carcinoma. His research activities have addressed questions in the field of primary liver cancer (focusing on both diagnostic and therapeutic interventions), liver transplantation and abdominal ultrasound, with particular interest in innovative techniques (Doppler ultrasound, contrast ultrasound and ultrasound elastography) and complications of liver cirrhosis.